The activation of Nuclear Factor κ B (NF-κB) in vascular endothelial cells, in response to biochemical or biomechanical stimuli, is associated with vascular pathologies such as atherosclerosis. The present manuscript studies the ability of the natural antioxidantpomegranate wine (PW), to inhibit tumor necrosis factor α (TNF-α) or shear stress-mediated-NF-κB activation in vascular endothelial cells and compares it to that of red wine (RW) and Nacetyl cysteine (NAC). PW and RW act as potent antioxidants in vascular endothelial cells, inhibiting the oxidation of 2',7'-dichloroflurescin diacetate in TNF-α treated cells. PW (as well as RW and NAC) acted as potent inhibitors of NF-κB activation (migration into the nucleus and DNA binding activity) in vascular endothelial cells. Nevertheless, PW and NAC failed to inhibit TNF-α induced serine 32/36 phosphorylation and IκBα degradation. Surprisingly, these antioxidants alone induced enhanced IκB serine phosphorylation, which was not accompanied by IκBα degradation, or NF-κB nuclear translocation. This phosphorylation did not involve serine 32/36. Furthermore, we show for the first time that NAC inhibited TNF-α mediated phosphorylation of p65 (ser536), whereas PW had no effect on this phosphorylation. Thus, natural antioxidants may serve as potent NF-κB inhibitors in vascular endothelial cells, yet act through unique and divergent pathways.
Oxidative stress, defined as an imbalance between oxidants and antioxidants, leads to modifications in biochemical properties of biomolecules (2) and to the formation of reactive oxygen species (ROS) in the cells, resulting in physiological dysfunction (3) .
Antioxidants are compounds, capable of eliminating the reactivity of free radicals without becoming reactive themselves. Plants are a good source for natural antioxidants because they contain a variety of phenolic compounds called flavonoids, which possess antioxidant activity and can be easily administrated as food supplements (4) . Red wine (RW), a well-studied natural antioxidant, was demonstrated to reduce the oxidation of blood LDL (5) and to inhibit the development of atherosclerosis in hyperlipidemic mice (6) . Pomegranate wine (PW), a natural antioxidant recently identified by us, is a potent antioxidant with inhibitory activity of eicosanoid oxidative enzymes (7) . Although the effect of PW on the cardiovascular system has not been reported so far, antioxidative activity of pomegranate juice has been reported in vivo, in human subjects and in hyperlipidemic mice (8) .
Nuclear factor κ B (NF-κB)-a family of transcription factors that has been extensively studied in the past 10 years, was suggested to play a pivotal role in tumorogenesis, inflammation, and cellular processes such as cell cycle and apoptosis (9, 10) . NF-κB activation occurs both in vitro and in vivo in response to various stimuli and is initiated via the rapid phosphorylation of the inhibitor IκB on serine residues 32/36 by several serine kinases, among them IκB kinases (IKK's) and NF-κB inducing kinase (NIK) (11, 12) . This phosphorylation leads to IκB degradation by the proteasome pathway, and the migration of NF-κB into the nucleus. Recently additional steps were added to this activation cascade and include the phosphorylation of the NF-κB members themselves, phosphorylation that is correlated with the binding of the nuclear NF-κB to the DNA and the formation of nuclear complexes with transcription factors co-activators or repressors (13) . The role of NF-κB in the transcriptional control of many inflammatory genes, such as cytokines, chemokines, growth factors, and leukocyte adhesion molecules (14) and the involvement of ROS in its activation, made NF-κB a preferred target for inhibition by various reagents among them antioxidants. NF-κB activation, which is followed in vitro by elevation in free radicals level, was demonstrated to be inhibited by antioxidants such as N-Acetyl Cysteine (NAC) (15) , gallates, cafeic acid, curcumin, and others (16) (17) (18) .
In the present study the effect of natural antioxidants, PW and RW on TNF-α and shear stressmediated activation of NF-κB in vascular endothelial cells was studied and compared with that of NAC. We have demonstrated that, although all three reagents are potent antioxidants and inhibitors of NF-κB activation (migration into the nucleus and DNA binding activity), they do not inhibit TNF-α induced serine phosphorylation on residues 32/36, or degradation of IκBα. Rather, these antioxidants caused enhanced IκB phosphorylation on residues other than 32/36, which was not accompanied by IκBα degradation or NF-κB nuclear translocation. Furthermore, NAC, but not PW, inhibited serine phosphorylation of p65 on residue 536. Thus, natural antioxidants are indeed powerful inhibitors of NF-κB activation, mediated by both biochemical and biomechanical stimuli in endothelial cells. Nevertheless, their mechanism of action is unique and specific to each of the compound tested.
MATERIALS AND METHODS

Reagents
RW cabernet sauvignon, matured for one year in oak barrels, and PW, from mixed cultivars, fermented with the wine yeast, Sacharomyces bayanus, were de-alcoholized and concentrated by freeze drying.
Cell culture
Primary bovine aortic endothelial cells (BAEC) were prepared as previously described (19) and grown to confluence in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% calf serum. For shear stress experiments, cells were plated on gelatin-coated polystyrene plates. Twenty-four hours before each experiment the cultures were serum-starved with medium containing 0.5% calf serum. Cultures were treated with RW, PW (4 µg/ml), or NAC (20 mM) for 2 h, before the addition of TNF-α [(200 U/ml) Pepro Tech Inc., Rocky Hill, NJ]. For shear stress experiments, cells were subjected to shear stress of 10 dyns/cm 2 for changing periods of time by using the cone and plate apparatus (19) . Experiments terminated by the removal of the medium and the addition of ice cold PBS.
Oxidation of H 2 DCFDA in BAEC
Confocal microscopy was used to follow the oxidation of 2',7'-dichloroflurescin diacetate (H 2 DCFDA) (Molecular Probes, Eugene, OR) by ROS in situ (20) . BAEC were seeded on fibronectin-coated, eight-chamber tissue culture glass slides at concentrations of 10,000-20,000 cells/well and were treated as described above. Cells were pretreated with RW or PW (2µg/ml) for 1 h;, the medium was removed and replaced with PBS supplemented with H 2 DCFDA (5 µM) and TNF-α (200 U/ml). Confocal microscopy (Zeiss LSM 410 confocal laser scanning microscope) was used in order to follow H 2 DCFDA oxidation in the cultures. The system was equipped with an air-cooled argon laser. Fluorescent images were collected by using a 63 × 1.2 C-apochromate water-immersion lens (Zeiss), and oxidation level was standardized to fluorescence per cell number by using image-pro software.
Preparation of cellular extracts and Western blot analysis
Cytosolic and nuclear proteins from BAEC were obtained as previously described (21) . For whole cell extracts, cells were washed X3 in PBS containing 1mM Na 3 Vo 4 , harvested, and lysed in Lysis Buffer (20 mM Tris, ph 7.5; 150 mM NaCl; 1 mM Na 3 Vo 4 ; 5mM EDTA; 1% Triton; 10% glycerol; 1 mM DTT; 1 mM PMSF; 1 µg/ml leupeptin. Cytosolic, nuclear, or whole cell extracts proteins (40-150 µg) were subjected to electrophoresis on 10% SDS-polyacrylamide gels and electro-transferred onto nitrocellulose membranes. Membranes were blocked for 1 h in 5 % nonfat dry milk in TBS, 0.05% tween 20, except when anti phosphoserine antibodies were used, where blocking was carried in 5% BSA in TBS, 0.05% tween 20. Blots were incubated overnight at 4°C with primary antibodies (0.5 µg/ml) in their blocking solution, followed by 1 h incubation with horseradish peroxidase (HRP)-conjugated Protein A/G (1:5000 dilution, Pierce, IL). Alternatively blots were incubated overnight at 4°C with anti rabbit secondary antibody conjugated to HRP (1:2000 dilution, Cell Signaling, MA) and anti biotin antibody conjugated to HRP (1:1000 dilution, Cell Signaling, MA). Proteins were detected by a chemoiluminescence kit (LumiGlo, Cell Signaling, MA). All experimental procedures where repeated five to six times.
Antibodies
Anti p65, anti IκBα (Santa Cruz Biotechnology, Santa Cruz, CA), anti phosphoserine (Calbiochem, SD, CA), anti phospho-IκBα (ser32), anti phospho-NF-κB p65 (ser536) (Cell Signaling, MA).
Statistical analysis
Immunoblots were quantified by using Vilber Lourmat densitometer (Bio cap-1 software). All values are reported as mean ± SEM. Statistical significance was calculated using an ANOVA two tailed t-test, and set as P<0.05.
RESULTS
Red Wine (RW) and Pomegranate Wine (PW) inhibit the oxidation of H 2 DCFDA in TNF-α treated vascular endothelial cells
It was long demonstrated that RW, and more recently that PW, can scavenge free radicals and inhibit oxidation both in vitro and in vivo. To test the antioxidant activity of RW and PW in situ, arterial EC cultures were pretreated with the antioxidants for 1 h before the simultaneous addition of H 2 DCFDA (5 µM) and TNF-α (200 U/ml). Differential interference contrast images were collected by a confocal microscope by using a transmitted light detector (Fig. 1) . Treatment of TNF-α alone resulted in excessive oxidation of H 2 DCF over control-untreated cultures. Quantification of the data (four fields for each condition, of the ratio fluorescent cells/total cells, by using Image-pro 4 software) revealed a fourfold increase in TNF-treated cells, implying for the formation of ROS. Cultures pretreated with the antioxidants RW, or PW (2 µg/ml) demonstrated up to 20-fold less oxidation of H 2 DCF compared with cultures treated with TNF-α alone and up to fourfold less oxidation compared with untreated cultures, indicating a strong in situ antioxidant activity of both agents.
Inhibition of NF-κB activation by RW, PW, and NAC in EC
Recent studies demonstrated that treatment of vascular endothelial cells with NAC prior to their exposure to TNF-α results in the inhibition of nuclear translocation of p65. To test the activity of RW and PW as NF-κB inhibitors and to compare it with the activity of NAC, BAEC cultures (passages 3-6) were pretreated with RW or PW (4 µg/ml) for 2 h and then were exposed to TNF-α (200 U/ml) for 5 to 40 min. Nuclear and cytosolic fractions were tested for the presence of p65. TNF-α treatment alone resulted in a rapid (5 min) migration of p65 from the cytoplasm into the nucleus; whereas pretreatment with RW, PW, or NAC inhibited this migration (two-to fourfold; Figs. 2A and B) . Inhibition of p65 nuclear translocation by these antioxidants was accompanied by inhibition of p65 binding activity, revealed by electro mobility shift assay (data not shown). NF-κB inhibition by these antioxidants was also observed when endothelial cells were exposed to a biomechanical stimulus-physiological levels of laminar shear stress (10 dynes/cm 2 ), for 30 min (Fig. 2C) . Reduced levels of p65 in the nucleus following antioxidant treatment were not the result of changes in the expression of the molecule, as revealed by Western blot analysis of whole cell extracts (Fig. 2D) . We examined further three isolated compounds from RW and PW, previously reported as bioactive antioxidants quercetin, catechin, and gallic acid, for their ability to inhibit p65 nuclear translocation in TNF-treated cell. All three compounds significantly inhibited TNF-α induced p65 translocation with gallic acid being the most potent inhibitor (Fig. 3) .
Pretreatment with PW or NAC does not affect IκBα phosphorylation or degradation in TNF-α treated BAEC
Treatment of endothelial cells with TNF-α leads to a rapid serine phosphorylation of IκBα (Figs. 4A and B), followed by a rapid degradation of the molecule (Figs. 4A and B) . As RW, PW, and NAC inhibited p65 nuclear translocation and binding to the DNA, we wanted to test whether the inhibition occurred through the stabilization of IκBα. To that end, whole cell extracts were prepared from untreated BAEC cultures, treated with TNF-α for various time points or treated with the antioxidants before the addition of TNF-α. Samples were tested for serinephosphorylation of IκBα with an anti-phosphoserine antibody and for the levels of IκBα with an anti IκBα antibody (Figs. 4A and B) . In TNF-α treated cultures, IκBα serine phosphorylation was evident as early as 5 min after the treatment. To our surprise, pretreatment of BAEC with either PW or NAC, before their exposure to TNF-α, did not result in inhibition of this phosphorylation. IκBα degradation, following TNF-α treatment, was not inhibited by NAC or PW, as complete disappearance of the molecule was evident 10 min after the addition of TNF-α alone, as well as in the presence of the antioxidants.
In TNF-α treated endothelial cells, IκBα was re-synthesized 40 min after the treatment; whereas in PW and TNF-α treated cells this de novo synthesis was not observed (Fig. 4B) . However, in cells treated with NAC and TNF-α, IκBα was re-synthesized (Fig. 4A) .
NAC but not PW inhibit TNF-α mediated p65 phosphorylation
Recently, the phosphorylation of NF-κB was suggested as an additional step in the cascade of events leading to NF-κB activation. This phosphorylation is correlated with the binding of the nuclear NF-κB to the DNA and the formation of nuclear complexes with transcription factors coactivators or repressors (13) . As NAC and PW inhibited NF-κB activation, but had no effect on IκBα phosphorylation or degradation, we tested their effect on TNF-α mediated p65 phosphorylation. To that end endothelial cells were treated with TNF-α alone, NAC or PW alone, or the combination of both, and cellular extract was tested for p65 phosphorylation on serine residue 536 ( Fig. 4C and D) . In cells stimulated with TNF-α p65 phosphorylation was evident 5-10 min after the treatment. Neither NAC nor PW alone had any effect on p65 basal phosphorylation. However, if added before TNF-α, NAC inhibited p65 phosphorylation on serine residue 536, whereas PW had no effect on TNF-α mediated p65 phosphorylation.
NAC and PW lead to a rapid serine phosphorylation of IκBα on serines other than 32
Interestingly, pre-incubation with NAC or PW before the addition of TNF-α (Figs. 4A and B; NAC 0' or PW 0') resulted in IκBα serine-phosphorylation, which was not observed in control untreated cultures. To test the effect of NAC or PW alone on IκBα phosphorylation and degradation, EC were treated with NAC and PW for various time intervals without their exposure to TNF-α. Nuclear and cytoplasmic fractions were prepared from the cells and IκBα serine-phosphorylation (Fig. 5Aa and Ba), IκBα degradation ( Fig. 5Ab and Bb) and p65 nuclear translocation (Fig. 5Ac and Bc) were tested. To our surprise, short treatment of BAEC (10 min) with either NAC or PW resulted in impressive phosphorylation of IκBα on serine residues. Nevertheless, this phosphorylation was accompanied by neither IκBα degradation, nor the translocation of p65 into the nucleus.
The fact that NAC and PW did not inhibit TNF-α mediated-IκBα serine phosphorylation on one hand, and led to an independent serine phosphorylation of IκBα on the other, raised the question as to which serine residues are phosphorylated by each of the treatments. To address this question, endothelial cells were treated with TNF-α alone, NAC or PW alone, or the combination of both, and IκBα phosphorylation was tested in cellular extracts by an antibody that exclusively recognizes IκBα phosphorylated on serine residue 32 ( Fig. 5C and D) . Indeed, as previously reported, treatment of endothelial cells with TNF-α led to a rapid (5 min) IκBα phosphorylation on serine residue 32. Treatment with NAC or PW alone did not induce phosphorylation on residue 32 beyond control levels, which suggests that NAC and PW induce serine phosphorylation (as observed by an anti phosphoserine antibody, Fig. 4A and B) , on residue(s) other than ser32. Furthermore, treatment of the cells with NAC or PW before the addition of TNF-α did not inhibit IκBα phosphorylation on serine residue 32.
DISCUSSION
In the present study we tested the inhibition of NF-κB activation in arterial endothelial cells by three antioxidants-PW, a natural antioxidant recently characterized by our group, RW, a wellstudied natural antioxidant and NAC. We report that both PW and RW, in minute pharmacological concentrations, exhibited antioxidant properties in vascular endothelial cells, as tested by their ability to inhibit the oxidation of linoleic acid (data not shown), as well as, TNF-α mediated oxidation of H 2 DCFDA. Pretreatment of arterial endothelial cells with either PW or NAC resulted in the inhibition of TNF-α, and shear stress-mediated NF-κB activation, shown by the inhibition p65 nuclear translocation and in reduced binding of p65 to its cognate DNA. Inhibition of TNF-α mediated NF-κB activation by PW and RW was observed at concentrations as low as 0.5 µg/ml. Maximum inhibition was achieved at the concentration range of 4 µg/ml to 250 µg/ml with no toxicity to the cells (data not shown). The optimal inhibitory effect of PW and RW required a minimum preincubation time of 2 h. Interestingly, neither TNF-α mediated IκBα phosphorylation, nor its degradation, was affected by these antioxidants. Rather, treatment of arterial EC with these antioxidants alone resulted in a strong and rapid serine-phosphorylation of IκBα, phosphorylation, which was neither accompanied by IκBα degradation, nor by the nuclear translocation of p65. We determined further that neither NAC nor PW inhibited TNF-α mediated IκBα phosphorylation on serine residue 32, which suggests that these antioxidants alone stimulate the phosphorylation of IκBα on residue(s) other than ser32. Furthermore, NAC but not PW inhibited TNF-α mediated p65 phosphorylation on serine 536.
Many vascular diseases result from or accompanied by inflammatory processes, where the activation of the transcription factor NF-κB plays a central role (22, 23) . Among these diseases is atherosclerosis, where the presence of activated NF-κB in the lesions was demonstrated recently (24) . Inflammatory genes, such as cytokines and chemokines, leukocyte-adhesion molecules, growth factors, and matrix-degrading enzymes, contain NF-κB sites in their promoters and are induced when NF-κB is activated (14) . It is therefore natural that in recent years much effort has been put in developing NF-κB inhibitors (25) . Nonetheless, administration of recently developed inhibitors often requires complicated molecular approaches (gene delivery) and may prove expensive. Thus, the use of natural antioxidants, which are safe and cheap, provides an attractive alternative approach. In the past three years, several natural antioxidants, such as curcumin (18), gallic acid (16) , and quercetin (26) have been reported to inhibit the activation of NF-κB, mediated by cytokines in endothelial and non-endothelial cell lines. RW, a well-established antioxidant, was demonstrated to suppress NF-κB activation in human mononuclear cells in vivo (27) . The cytokine-induced NF-κB inhibiting activity in RW is attributed to its polyphenolic content. Several phenolic compounds in red wine such as resveratrol (28), gallic acid (16), caffeic acid (17), quercetin (26) and catechin have been found by us to exhibit cytokine induced NF-κB inhibition in arterial endothelial cells. We have recently demonstrated that PW flavonoids suppresses eicosanoid metabolism by inhibiting cyclooxygenase and lipoxygenase (7) . This activity may count in part for the ability of PW to inhibit NF-κB activation (29) .
Is there a general mechanism through which natural antioxidants inhibit NF-κB activation? Multiple steps in the activation pathway of NF-κB by various stimuli can be marked as targets for the inhibition of NF-κB activation. Starting by the inhibition of the recently identified IκB kinases (IKKs, NIK) on the level of their activation (phosphorylation) (30), or expression, inhibition of IκB ubiquitination and degradation by the proteasome complex (31) and inhibition of NF-κB phosphorylation (13) . It is thus of extreme importance to define the exact step in NF-κB activation cascade inhibited by each drug, as synergistic effects of several drugs may be advantageous resulting in complete inhibition of NF-κB activation. The inhibition of cytokine mediated NF-κB activation by the antioxidants salicylates and by curcumin was demonstrated to result from the inhibition of IκB phosphorylation and degradation (18, 32) . The recently identified IκB kinases, IKKα, and IKKβ are inhibited by these antioxidants, at the level of activation (phosphorylation). These compounds also inhibit the activation of additional kinases, such as the mitogen activated protein 3 (MEKK1), resulting in the inhibition of down-stream transcription factors, such as TPA response element (TRE), fos, and jun (33) (34) (35) . Thus, it may be postulated that these antioxidants act on the cells in early steps of the signaling cascade, although their specific target has not yet been identified.
Additional antioxidants, such as gallates (16) , caffeic acid phenethyl ester (CAPE) (17) , N-tosyl-L-phenylalanine chloromethyl ketone (36, 37) , and herbimycin A (38), inhibit NF-κB activation (binding to the DNA or nuclear translocation), not through the inhibition of IκB phosphorylation or degradation. S-nitrosylation of p50 or p65 on cysteine residues by N-tosyl-L-phenylalanine chloromethyl ketone (36) inhibits the ability of the p50/p65 heterodimer to bind to the DNA, but has no effect on its nuclear translocation (37) . CAPE and gallates both inhibit NF-κB nuclear translocation and binding to the DNA, through an unknown mechanism, and do not affect cytokine-mediated IκBα degradation. Our data demonstrated that treatment of arterial endothelial cells with PW, RW, or NAC, which resulted in the inhibition of NF-κB activation by biochemical (TNF-α) or biomechanical (shear stress) stimuli, had no effect on IκBα phosphorylation or degradation. Treatment with these reagents alone resulted in a fast serine phosphorylation of IκBα on serine residues other than 32, which was not accompanied by IκBα degradation. Nevertheless, NAC and PW diverge in the mechanisms through which they inhibit NF-κB activation. Using antibodies specific to serine 536-phosphorylated-p65-we have shown that NAC, but not PW, inhibited TNF-α mediated p65 phosphorylation. Thus, NAC inhibits NF-κB activation by directly affecting p65. Interestingly, the phosphorylation of both IκBα and p65 is attributed to the IKK complex (11, 39) . The fact that NAC inhibited p65 but not IκBα phosphorylation may point to a differential inhibition of IKK activity by NAC, or may alternatively suggest the presence of an additional kinase. A very recent study, demonstrated that in contrast to IKKβ, which is required for both IkB and p65 phosphorylation, IKKα is solely required for cytokine mediated p65 phsophorylation (40) .
It remains to be studied what is the mechanism through which PW inhibits NF-κB activation, and whether this inhibition is exclusive to NF-κB. We have found recently that in TNF-α treated endothelial cells the migration of egr1 into the nucleus is also inhibited by PW (Schubert S., unpublished results). Thus PW mechanism of inhibition may involve trafficking into and out of the nucleus.
NAC and PW also differed in their effect on IκBα de novo synthesis. Where this synthesis occurred in cells treated with TNF-α alone or in combination with NAC, it was not observed in cells treated with TNF-α and PW. As IκBα de novo synthesis was shown to be dependent on NF-κB (41), it is not surprising that PW, which inhibits NF-κB activation, also inhibits IκBα resynthesis. It is not clear, however, why in NAC treated cells IκBα de novo synthesis is unaffected, unless alternative transcription factors promote this synthesis.
Thus, different antioxidants inhibit NF-κB activation via multiple mechanisms, which may depend on the properties of the antioxidant, its specific target in the treated cell, or the origin of the treated cells. Development of novel NF-κB inhibitory drugs bares an important significance in the prevention and treatment of cardiovascular diseases. Natural antioxidants originated from food substances, such as red wine and pomegranate wine, have a huge advantage over existing drugs being non-toxic and inexpensive. Their potency as NF-κB inhibitors in arterial endothelial cells in culture on one hand, and the novel mechanism through which they inhibit NF-κB activation pathway, provide a strong rational for further studying these reagents both in vitro and in vivo. RW (2 µg/ml) for 1 h, prior to the addition of TNF-α (200 U/ml) and H 2 DCFDA (5 µM). H 2 DCFDA oxidation was followed for 30 min and measured by confocal microscopy by using a Zeiss LSM 410 confocal laser scanning microscope. The system was equipped with an air-cooled argon laser. The fluorescence was collected by 63×/1.2 C-apochromate water immersion lens (Zeiss). Differential interference contrast images were collected by using a transmitted light detector. treated with PW (4 µg/ml), RW (4 µg/ml), or NAC (20 mM) for 2 h before their incubation with TNF-α (200 U/ml) for 5, 10, and 40 min. Nuclear extracts were prepared, and the presence of p65 was tested (A). Quantitative analysis of the blots (n=6) was performed by using scanning densitometry. Statistically significant inhibition of p65 nuclear translocation by PW, RW, and NAC in TNF-treated cells can be observed (B). BAEC were treated with PW (4 µg/ml), RW (4 µg/ml), or NAC (20 mM) for 2 h before to their exposure to physiological levels of laminar shear stress (10 dynes/cm 2 ;30min). Nuclear extracts were prepared (n=5), and the presence of p65 was tested (C). BAEC were treated with PW (4 µg/ml), RW (4 µg/ml), or NAC (20 mM) for 2 h before their incubation with TNF-α (200 U/ml) for 5, 10, and 40 min. Whole cell extracts were prepared (n=5), and the presence of p65 was tested (D), demonstrating that the total quantity of p65 in the cells is not altered by the antioxidants. NF-κB activation in BAEC. BAEC were pretreated with quercetin, catechin, or gallic acid (3 µM) for 2 h, before their incubation with TNF-α (200 U/ml) for 40 min. Nuclear extracts were prepared, and p65 translocation to the nucleus was tested (A). Quantitative analysis of the blots (n=4) was performed by using scanning densitometry. Statistically significant inhibition of TNF-mediated p65 nuclear translocation by all three compounds can be observed (B). phosphorylation. Cultured BAEC were untreated; treated with TNF-α (200 U/ml) for 30 min; or treated with NAC (20 mM) (A), or PW (4 µg/ml) (B) for 10, 30, 60, and 120 min (n=3). Cytosolic (cyto) and nuclear (nuc) extracts were prepared and tested for IκBα serine phosphorylation (a), degradation (b), and p65 nuclear translocation (c). Cultured BAEC were untreated; treated with TNF-α (200 U/ml) for 30 min or were treated with NAC (20 mM) (C); or PW (4 µg/ml) (D) for 10, 30, 60, and 120 minutes (n=3). Whole cell extracts were prepared and tested for IκBα 32-serine phosphorylation, or degradation.
